Experimental Murine Models for Colorectal Cancer Research

Area of Science:

• Oncology
• Translational Research
• Preclinical Models

Background:

• Colorectal cancer (CRC) is a leading global malignancy, necessitating robust research models.
• Existing murine models include carcinogen-induced models (CIMs) and genetically engineered mouse models (GEMMs).
• CIMs are useful for studying inflammation-driven carcinogenesis and chemoprevention strategies.

Purpose of the Study:

• To review and compare diverse murine models for colorectal cancer (CRC) research.
• To evaluate the clinical relevance, advantages, and limitations of each model type.
• To highlight the utility of models in understanding CRC biology and developing therapies.

Main Methods:

• Review of established carcinogen-induced models (CIMs) for CRC.
• Analysis of genetically engineered mouse models (GEMMs) for CRC.
• Evaluation of patient-derived xenografts (PDX) for preclinical drug development.

Main Results:

• GEMMs are valuable for studying the tumor microenvironment and immune responses in CRC.
• Orthotopic injection models have limitations due to restricted genetic diversity of cell lines.
• Patient-derived xenografts (PDX) best retain the pathological and molecular characteristics of human CRC.

Conclusions:

• Murine CRC models are crucial for advancing CRC understanding and treatment.
• Patient-derived xenografts (PDX) are highly reliable for preclinical drug development.
• Further research is needed to develop models that fully recapitulate CRC pathophysiology.